ADX-N05
Sponsors
Jazz Pharmaceuticals
Conditions
Narcolepsy
Phase 2
A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness
CompletedNCT01485770
Start: 2011-12-31End: 2012-05-31Updated: 2021-07-06
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
CompletedNCT01681121
Start: 2012-09-30End: 2013-08-31Updated: 2021-05-28